$173.08
$19.90 for a single vial
SKU RT30
Retatrutide 30mg
$599.40
Per sealed kit · 10 vials
Retatrutide is a triple agonist at the GIP, GLP-1, and glucagon receptors, investigated for combined effects on appetite, energy expenditure, and lipid metabolism.
Ships as one factory-sealed kit of ten individually capped vials from our weight management collection, cold-chain packed with written order confirmation. Need the other size? Flip the toggle above.
1
- Kit contents
- 10 sealed vials
- Collection
- Weight Management
- Shipping
- Cold-chain, from Boise, ID
- Intended use
- Laboratory research only
About Retatrutide 30mg
Retatrutide is a triple agonist acting at the GIP, GLP-1, and glucagon receptors. The added glucagon-receptor activity distinguishes it from dual agonists: alongside appetite suppression, it drives increased energy expenditure and hepatic lipid mobilization, making it the most aggressive of the incretin research compounds.
Because three pathways are engaged at once, research designs treat titration conservatively. Effects on appetite typically appear within the first one to two weeks, while changes in energy expenditure and lipid endpoints emerge over longer observation windows.
Available as a single vial or a factory-sealed kit of ten individually capped vials. Every order is packed cold with a written order confirmation and batch reference, so each vial can be traced back to its certificate of analysis.
Reported benefits in research
- Strongest appetite suppression of the incretin class in comparative research
- Increased resting energy expenditure via glucagon-receptor activity
- Mobilization of hepatic and visceral lipid stores
- Improved glucose handling and insulin sensitivity
- Once-weekly administration
How to use it
- Allow the sealed vial to reach room temperature before opening; do not open a vial that is still cold.
- Wipe the rubber stopper with an alcohol prep pad and let it dry.
- Draw the diluent volume called for in your protocol (bacteriostatic water for nearly all peptides, including GHK-Cu; dilute acetic acid water only for sequences that need a low pH, such as IGF-1 LR3) and inject it slowly against the inner glass wall of the vial.
- Swirl gently until fully clear — never shake, as agitation can fracture the peptide chain.
- Begin at the lowest weekly dose in your protocol and allow at least four weeks at each step before considering an increase; the added glucagon activity makes slow titration the standard research approach.
- Label the vial with the compound, concentration, and reconstitution date, then return it to refrigeration between uses.
What it’s studied for
- Appetite suppression pathways
- Energy expenditure and lipid metabolism
- Advanced metabolic research endpoints
Recommended protocol
Research designs generally begin at the lowest weekly dose with extended four-week intervals between increases, given the added glucagon-receptor activity. Reconstitute with bacteriostatic water and swirl gently.
Storage & handling
Store lyophilized vials refrigerated (2–8°C) and protected from light. Once reconstituted with bacteriostatic water, keep refrigerated and use within the window cited in your research protocol.
Lab results
Independent certificates of analysis for the batches behind this product. Click a report to open the full PDF.
See all lab resultsAll products are sold for laboratory and research use only. Protocol information is a summary of commonly referenced research designs and is not medical advice, a prescription, or a recommendation for human consumption.
More from Weight Management
$194.40
$22.36 for a single vial
$226.80
$26.08 for a single vial